Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1011-1020 of 1772 for cancer

Edit search filters
  1. Safety And Preliminary Efficacy Assessment Of AZD7789 In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma

    Rochester, MN

  2. A Study To Evaluate Pevonedistat, Azacitidine (Or Decitabine), And Venetoclax (PAVE) To Treat Acute Myelogenous Leukemia (AML) Patients

    Rochester, MN

  3. A Study To Determine Recommended Dose, Regimen And Evaluate The Safety And Preliminary Effectiveness Of CC-92480 In Combination With Standard Treatments In Subjects With Relapsed Or Refractory Multiple Myeloma (RRMM) And Newly Diagnosed Multiple Myeloma (NDMM)

    Rochester, MN

  4. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, And Tecentriq Treatment Targeted Against Certain Molecular Alterations In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Assess The Safety And Antitumor Activity Of Genetically Engineered T Cells In NY-ESO-1 And/or LAGE-1a Positive Solid Tumors

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate CC-96191 To Treat Participants With Relapsed Or Refractory Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  7. Venetoclax, Ixazomib Citrate, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma

    Rochester, MN

  8. Idasanutlin, Ixazomib Citrate, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate The Safety And Effectiveness Of Metformin And Nelfinavir With Bortezomib In Patients With Relapsed And/or Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  10. A Phase 1/2a Dose-Finding Study Of PT-112 In Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer